Chris L. Berendsen
Papers
2
Total Citations
69
H-Index
2
About
Chris L. Berendsen is a leading urologic oncologist whose research focuses on advancing surgical outcomes for bladder cancer patients, particularly through the comparative effectiveness of robot-assisted versus open radical cystectomy. His major contributions include spearheading a multicentre comparative effectiveness study that rigorously evaluated clinical outcomes between these two surgical approaches, providing crucial evidence for treatment decision-making. This landmark work, which has garnered 53 citations, demonstrated key differences in recovery and complication rates, influencing surgical practice guidelines. Berendsen further extended this research with an economic evaluation, published in 2021, which analyzed the cost-effectiveness of robot-assisted surgery alongside clinical benefits—a study that has accumulated 16 citations and offers valuable insights for healthcare resource allocation. His work is notable for its pragmatic, patient-centered design and its integration of clinical and economic outcomes, making it highly relevant for surgeons, policymakers, and researchers seeking to optimize bladder cancer care. Berendsen’s research continues to shape the evidence base for minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2